A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,227 shares of CTLT stock, worth $602,472. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,227
Previous 7,688 33.03%
Holding current value
$602,472
Previous $432,000 43.29%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $142,590 - $154,777
2,539 Added 33.03%
10,227 $619,000
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $14,895 - $15,851
278 Added 3.75%
7,688 $432,000
Q1 2024

May 09, 2024

BUY
$42.56 - $59.82 $41,581 - $58,444
977 Added 15.19%
7,410 $418,000
Q4 2023

Feb 07, 2024

SELL
$32.18 - $46.57 $66,033 - $95,561
-2,052 Reduced 24.18%
6,433 $289,000
Q3 2023

Nov 08, 2023

BUY
$44.2 - $50.2 $19,713 - $22,389
446 Added 5.55%
8,485 $386,000
Q2 2023

Jul 28, 2023

SELL
$31.86 - $67.26 $117,499 - $248,054
-3,688 Reduced 31.45%
8,039 $348,000
Q1 2023

May 10, 2023

BUY
$45.44 - $74.26 $145,862 - $238,374
3,210 Added 37.69%
11,727 $770,000
Q4 2022

Feb 10, 2023

BUY
$41.39 - $81.0 $26,779 - $52,407
647 Added 8.22%
8,517 $383,000
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $101,593 - $158,792
-1,404 Reduced 15.14%
7,870 $569,000
Q2 2022

Aug 09, 2022

BUY
$87.2 - $114.05 $315,838 - $413,089
3,622 Added 64.08%
9,274 $995,000
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $95,414 - $126,108
1,013 Added 21.84%
5,652 $627,000
Q4 2021

Feb 23, 2022

BUY
$119.57 - $139.07 $64,567 - $75,097
540 Added 13.17%
4,639 $594,000
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $69,650 - $90,819
638 Added 18.43%
4,099 $545,000
Q2 2021

Aug 11, 2021

BUY
$100.34 - $115.69 $347,276 - $400,403
3,461 New
3,461 $374,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.